Donald Healey
Net worth: 29 825 $ as of 2026-06-29
Net worth: 29 825 $ as of 2026-06-29
Donald Healey currently works at Adicet Bio, Inc., as Chief Technology Officer from 2020.
Dr. Healey also formerly worked at Argos Therapeutics, Inc., as Director-Immunology, KBI Biopharma, Inc., as Senior Vice President-Operations from 2017 to 2020, Opexa Therapeutics, Inc., as Chief Scientific Officer from 2013 to 2017, and British Society for Immunology, as Council Member in 1998.
Dr. Healey received his doctorate degree from the University of London and undergraduate degree from the University of Bristol.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ADICET BIO INC 0.04% | 2026-03-24 | 3,452 ( 0.04% ) | 29 825 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| ADICET BIO, INC. | Chief Tech/Sci/R&D Officer | 2020-10-25 |
| Companies | Position | End |
|---|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Chief Operating Officer | 2020-09-30 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Chief Tech/Sci/R&D Officer | 2017-01-31 |
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services Provides membership organizations services | Corporate Officer/Principal | 1997-12-31 |
| ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Commercial Services |
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services Provides membership organizations services | Commercial Services |
Adicet Bio, Inc.
Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions